Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5175691
Max Phase: Preclinical
Molecular Formula: C32H29F8N9O2
Molecular Weight: 723.63
Associated Items:
ID: ALA5175691
Max Phase: Preclinical
Molecular Formula: C32H29F8N9O2
Molecular Weight: 723.63
Associated Items:
Canonical SMILES: C[C@@H](N1CCN(c2ccc(-n3cnn(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3=O)nc2)CC1)[C@](O)(Cn1cncn1)c1ccc(F)cc1F
Standard InChI: InChI=1S/C32H29F8N9O2/c1-20(30(51,16-47-18-41-17-43-47)26-4-2-24(33)13-27(26)34)45-6-8-46(9-7-45)25-3-5-28(42-14-25)48-19-44-49(29(48)50)15-21-10-22(31(35,36)37)12-23(11-21)32(38,39)40/h2-5,10-14,17-20,51H,6-9,15-16H2,1H3/t20-,30-/m1/s1
Standard InChI Key: MCZDILFEHUBONL-PRAQEBQASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 723.63 | Molecular Weight (Monoisotopic): 723.2316 | AlogP: 4.48 | #Rotatable Bonds: 9 |
Polar Surface Area: 110.13 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.69 | CX Basic pKa: 7.13 | CX LogP: 5.57 | CX LogD: 5.38 |
Aromatic Rings: 5 | Heavy Atoms: 51 | QED Weighted: 0.22 | Np Likeness Score: -1.48 |
1. Ghobadi E, Saednia S, Emami S.. (2022) Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development., 231 [PMID:35134679] [10.1016/j.ejmech.2022.114161] |
Source(1):